Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer
Disodium pamidronate (Aredia®), a drug of the bisphosphonate group, was administered to 20 patients with pains in the bones due to secondary deposits of lung cancer. The aim of the study was to investigate the analgesic effect of pamidronate to osteolytic metastases of lung cancer in the bone. In 16...
Saved in:
| Main Authors: | Ranković Boško, Mrđa Vladimir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2002-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2002/0042-84500201033R.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients
by: Jauković Ljiljana, et al.
Published: (2006-01-01) -
Liver-first approach to the treatment of patients with synchronous colorectal liver metastases: a systematic review and meta-analysis
by: Bruno Mirandola Bulisani, et al.
Published: (2024-12-01) -
A case of synchronous intramucosal gastric carcinoma with multiple lymph node metastases
by: En Amada, et al.
Published: (2021-04-01) -
Cutaneous Metastasis in Advanced Gastric Cancer
by: André Silva, et al.
Published: (2025-01-01) -
Computed tomography Hounsfield unit values as a treatment response indicator for spinal metastatic lesions in patients with non-small-cell lung cancer: a retrospective study in Japan
by: Hiroshi Taniwaki, et al.
Published: (2025-02-01)